Abstract:PURPOSE:The present study was aimed at clarifying the expression of astrocyte elevated gene-1 (AEG-1), one of the target genes of oncogenic Ha-ras, in breast cancer and its correlation with clinicopathologic features, including the survival of patients with breast cancer.EXPERIMENTAL DESIGN:The expression of AEG-1 in normal breast epithelial cells, breast cancer cell lines, and in four cases of paired primary breast tumor and normal breast tissue was examined using reverse transcription-PCR and Western blot. Real-time reverse transcription-PCR was applied to determine the mRNA level of AEG-1 in the four paired tissues, each from the same subject. Furthermore, AEG-1 protein expression was analyzed in 225 clinicopathologically characterized breast cancer cases using immunohistochemistry. Statistical analyses were applied to test for the prognostic and diagnostic associations.RESULTS:Western blot and reverse transcription-PCR showed that the expression level of AEG-1 was markedly higher in breast cancer cell lines than that in the normal breast epithelial cells at both mRNA and protein levels. AEG-1 expression levels were significantly up-regulated by up to 35-fold in primary breast tumors in comparison to the paired normal breast tissue from the same patient. Immunohistochemical analysis revealed high expression of AEG-1 in 100 of 225 (44.4%) paraffin-embedded archival breast cancer biopsies. Statistical analysis showed a significant correlation of AEG-1 expression with the clinical staging of the patients with breast cancer (P = 0.001), as well as with the tumor classification (P = 0.004), node classification (P = 0.026), and metastasis classification (P = 0.001). Patients with higher AEG-1 expression had shorter overall survival time, whereas patients with lower AEG-1 expression had better survival. Multivariate analysis suggested that AEG-1 expression might be an independent prognostic indicator for the survival of patients with breast cancer.CONCLUSIONS:Our results suggest that AEG-1 protein is a valuable marker of breast cancer progression. High AEG-1 expression is associated with poor overall survival in patients with breast cancer.

Astrocyte Elevated Gene‐1 Interacts with Β‐catenin and Increases Migration and Invasion of Colorectal Carcinoma

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling

Astrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond

Astrocyte Elevated Gene-1 Promotes Progression of Cervical Squamous Cell Carcinoma by Inducing Epithelial-Mesenchymal Transition Via Wnt Signaling

Progress in Treatment for Malignant Tumors with Astrocyte Elevated Gene-1

Knockdown of Astrocyte Elevated Gene-1 Inhibits Tumor Growth and Modifies Micrornas Expression Profiles in Human Colorectal Cancer Cells.

Knockdown of astrocyte elevated gene-1 (AEG-1) in cervical cancer cells decreases their invasiveness, epithelial to mesenchymal transition, and chemoresistance.

Overexpression of Astrocyte Elevated Gene-1 (Aeg-1) is Associated with Esophageal Squamous Cell Carcinoma (escc) Progression and Pathogenesis

Astrocyte-elevated Gene-1 Overexpression is Associated with Poor Prognosis in Gastric Cancer.

Clinical significance and effect of AEG-1 on the proliferation, invasion, and migration of NSCLC: a study based on immunohistochemistry, TCGA, bioinformatics, in vitro and in vivo verification

Overexpression of Astrocyte-Elevated Gene-1 is Associated with Cervical Carcinoma Progression and Angiogenesis

Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.

AEG-1 is associated with tumor progression in nonmuscle-invasive bladder cancer

The key role of astrocyte elevated gene-1 in CCR6-induced EMT in cervical cancer

High expression of astrocyte elevated gene-1 is associated with clinical staging, metastasis, and unfavorable prognosis in gastric carcinoma

AEG-1 as a Novel Therapeutic Target in Colon Cancer: A Study from Silencing AEG-1 in BALB/c Mice to Large Data Analysis

Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival

Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis

Astrocyte Elevated Gene-1 is Associated with Metastasis in Head and Neck Squamous Cell Carcinoma Through P65 Phosphorylation and Upregulation of MMP1

Depletion of Astrocyte Elevated Gene-1 Suppresses Tumorigenesis Through Inhibition of Akt Activity in Bladder Cancer Cells.